EyePoint Pharmaceuticals (EYPT)

• Market cap: $1B
• 1 day: -0.48%
• 5 days: -0.56%
• 1 month: -9.03%
• 3 months: 23.16%
• 6 months: 80.61%
• Year to date: 54.3%
• 1 year: 5.9%
• 5 years: 208.98%
• 10 years: -68.15%
• Sector: Healthcare
• Industry: Biotechnology

About: EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Employees: 144